A carregar...
Electrophysiological Basis for the Antiarrhythmic Actions of Ranolazine
Ranolazine is an FDA-approved anti-anginal agent. Experimental and clinical studies have shown that ranolazine has anti-arrhythmic effects in both ventricles and atria. In the ventricles, ranolazine can suppress arrhythmias associated with acute coronary syndrome, long QT, heart failure, ischemia, a...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3131428/ https://ncbi.nlm.nih.gov/pubmed/21421082 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hrthm.2011.03.045 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|